{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:58Z","timestamp":1791356098548,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jconrel.2014.09.021","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T13:31:02Z","timestamp":1412083862000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways"],"prefix":"10.1016","volume":"196","author":[{"given":"Maria","family":"Lapteva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Santer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Mondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Patmanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Chiriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Scapozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-5489","authenticated-orcid":false,"given":"Yogeshvar N.","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.09.021_bb0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2010.503953","article-title":"Topical delivery for the treatment of psoriasis","volume":"7","author":"Mitra","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0020","series-title":"Neoral medication guide","author":"FDA.gov","year":"2009"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0025","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/jps.21485","article-title":"Bicontinuous cyclosporin a loaded water-AOT\/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo","volume":"98","author":"Liu","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9236(98)90042-X","article-title":"Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis","volume":"63","author":"Hirano","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0923-1811(00)00166-3","article-title":"Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis","volume":"26","author":"Umezawa","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/03639040500529168","article-title":"Bicontinuous water-AOT\/Tween85-isopropyl myristate microemulsion: a new vehicle for transdermal delivery of cyclosporin A","volume":"32","author":"Liu","year":"2006","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0045","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/jps.20898","article-title":"Gelatin-stabilised microemulsion-based organogels facilitates percutaneous penetration of Cyclosporin A in vitro and dermal pharmacokinetics in vivo","volume":"96","author":"Liu","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpb.2006.02.003","article-title":"Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery","volume":"63","author":"Lopes","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0055","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s11095-006-0143-7","article-title":"Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A","volume":"23","author":"Lopes","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10717540600642431","article-title":"Amphiphilic gels as a potential carrier for topical drug delivery","volume":"14","author":"Prasad","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0065","first-page":"510","article-title":"Topical administration of cyclosporin A in a solid lipid nanoparticle formulation","volume":"64","author":"Kim","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.03.036","article-title":"Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)","volume":"319","author":"Trimaille","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2010.09.012","article-title":"Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study","volume":"77","author":"Mondon","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbm.a.30888","article-title":"Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems","volume":"80A","author":"Trimaille","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharma.2011.01.001","article-title":"Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye","volume":"69","author":"Di Tommaso","year":"2011","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2010.02.006","article-title":"Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations","volume":"40","author":"Di Tommaso","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0095","series-title":"Novel PEG-hexPLA micellar drug carriers with a covalently labeled Nile Red fluorescence marker","author":"Trubitsyn","year":"2011"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1021\/ml1001272","article-title":"Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands","volume":"1","author":"Gaali","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0110","series-title":"Test No. 107: Partition Coefficient (n-octanol\/water): Shake Flask Method","author":"OECD Guidelines for the Testing of Chemicals","year":"1995"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0115","series-title":"International Conference on Harmonisation of Technical Requirments for registration of Pharmaceuticals for Human Use","article-title":"Validation of Analytical Procedures: Text and Methodology Topic Q 2 (R1)","year":"2005"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0120","series-title":"Food and Drug Adminstration","author":"Guidance for Industry, Bioanalytical Method Validation","year":"2001"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1751-1097.2010.00879.x","article-title":"MPEG-hexPLA micelles as novel carriers for hypericin, a fluorescent marker for use in cancer diagnostics","volume":"87","author":"Mondon","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2011.03.003","article-title":"Novel micelle formulations to increase cutaneous bioavailability of azole antifungals","volume":"153","author":"Bachhav","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0135","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.2042-7158.1992.tb05485.x","article-title":"Pig ear skin as an in-vitro model for human skin permeability","volume":"44","author":"Dick","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0846.2006.00179.x","article-title":"Porcine ear skin: an in vitro model for human skin","volume":"13","author":"Jacobi","year":"2007","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(00)00665-7","article-title":"Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption","volume":"215","author":"Schmook","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0150","article-title":"(ACD\/Labs) Software V11.02","volume":"4","author":"Scifinder, Calculated using Advanced Chemistry Development","year":"2014","journal-title":"(\u00a9 1994-2013 ACD\/Labs)"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nmat1469","article-title":"Fluorescein as a model molecular calculator with reset capability","volume":"4","author":"Margulies","year":"2005","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1467-2494.2006.00344.x","article-title":"Natural skin surface pH is on average below 5, which is beneficial for its resident flora","volume":"28","author":"Lambers","year":"2006","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-3659(00)00268-6","article-title":"Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl","volume":"68","author":"Liaw","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0304-4165(02)00415-4","article-title":"The in vivo and in vitro interactions of elastic and rigid vesicles with human skin","volume":"1573","author":"Honeywell-Nguyen","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0175","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1023\/A:1007648807195","article-title":"Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data","volume":"17","author":"Wagner","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2004.12.003","article-title":"Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer","volume":"60","author":"Lopes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0185","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1081\/DDC-100101304","article-title":"Monoolein: a review of the pharmaceutical applications","volume":"26","author":"Ganem-Quintanar","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1998.02166.x","article-title":"Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes)","volume":"138","author":"Schatzlein","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2008.08.006","article-title":"Pig skin structure and transdermal delivery of liposomes: a two photon microscopy study","volume":"132","author":"Carrer","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2009.10.016","article-title":"Nanotechnology and the transdermal route: a state of the art review and critical appraisal","volume":"141","author":"Cevc","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0005-2736(97)00273-3","article-title":"Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study","volume":"1371","author":"van Kuijk-Meuwissen","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2014.09.021_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000338976","article-title":"Safety assessment by multiphoton fluorescence\/second harmonic generation\/hyper-Rayleigh scattering tomography of ZnO nanoparticles used in cosmetic products","volume":"25","author":"Darvin","year":"2012","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2014.09.021_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.02.062","article-title":"The use of cyclosporine in dermatology: part II","volume":"63","author":"Ryan","year":"2010","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T18:54:06Z","timestamp":1538160846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914006646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":44,"alternative-id":["S0168365914006646"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.09.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}